Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pepper-Based patch tested against Kids' chronic nerve pain

NCT ID NCT05299294

Ongoing Symptom relief Sponsor: University Hospital, Brest Source: ClinicalTrials.gov ↗

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This study follows children aged 0 to 18 with chronic localized neuropathic pain who receive an 8% capsaicin patch as part of their routine care. Researchers will track whether the patch reduces pain and lessens the need for other pain treatments over six months. The goal is to see if this skin patch, derived from chili peppers, offers a safe and effective option for managing nerve pain in young patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an 8% capsaicin patch applied to the skin
What this could lead to
If successful, this could provide a non-drug option for managing chronic nerve pain in children, potentially reducing the need for other pain medications.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. Capsaicin can cause burning or stinging at the application site, and its effectiveness in children is not yet well established.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC PAIN NEUROPATHIC PAIN

Contacts and locations

Locations

  • CHR Bourg en Bresse

    Bourg-en-Bresse, France, 01000, France

  • CHRU Strasbourg

    Strasbourg, France, 67098, France

  • CHU Angers

    Angers, France, 49933, France

  • CHU Bordeaux

    Bordeaux, France, 33076, France

  • CHU Caen

    Caen, France, 14000, France

  • CHU Lille

    Lille, France, 59037, France

  • CHU Limoges

    Limoges, France, 87042, France

  • CHU Lyon

    Lyon, France

  • CHU Marseille

    Marseille, France, 13005, France

  • CHU Montpellier

    Montpellier, France, 34090, France

  • CHU Nancy

    Nancy, France, 54511, France

  • CHU Nantes

    Nantes, France, 44093, France

  • CHU Robert Debré

    Paris, France, 75019, France

  • CHU Rouen

    Rouen, France, 76031, France

  • CHU Toulouse

    Toulouse, France, 31059, France

  • CHU Tours

    Tours, France, 37044, France

  • CHU Trousseau

    Paris, France, 75571, France

  • CHU d'Amiens

    Amiens, 80054, France

  • CHU de Brest

    Brest, France, 29609, France

  • Institut Gustave Roussy

    Villejuif, France, 94805, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.